July 24, 2009

Synthesis and antiviral activity of Glycyrrhizin analogs

May 14, 2009

Glycyrrhizin, the main active compound in licorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signaling.

May 11, 2009

at Onepharm R&D GmbH, University of Veterinary Medicine campus

May 02, 2009

Glycyrrhizin inhibits Influenza A virus uptake into the cell.

April 20, 2009

Efficient synthesis of glycyrrhetinic acid glycoside/glucuronide derivatives using silver zeolite as promoter.

March 09, 2009

Selective inhibition of 11beta-hydroxysteroid dehydrogenase 1 by 18alpha-glycyrrhetinic acid but not 18beta-glycyrrhetinic acid

December 01, 2008

at Onepharm R&D GmbH, University of Veterinary Medicine campus

September 22, 2008

Differences in Binding of 18alpha- and 18beta-Glycyrrhetinic acid to 11beta-Hyxroxysteroid Dehydrogenase

August 04, 2008

Synthesis of Glycyrrhetinic Acid Glycosides

June 12, 2008

at the Jordis Hunting Lodge, Lower Austria

December 13, 2007

at Onepharm R&D GmbH, University of Veterinary Medicine campus

June 28, 2007

at the University of Natural Resources and Applied Life Sciences

March 27, 2006

Onepharm, a Vienna, Austria based biotech company specializing in the development of new antiviral drugs, has been awarded funding by the ZIT (Zentrum für Innovation und Technology, the Vienna Business Agency’s Centre for...

October 18, 2005

Two promising lead candidates against human rhinovirus and SARS, Scientific Advisory Board in place